IDEAYA Biosciences, Inc.
Pharmaceutical company · South San Francisco, California, United States · Nasdaq: IDYA
IDEAYA Biosciences, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker IDYA. It has reported private securities offerings to the US SEC, most recently $94 million sold in a notice filed in 2018.
IDEAYA Biosciences at a glance
What does IDEAYA Biosciences do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $94 million sold (2018).
Frequently asked questions about IDEAYA Biosciences
Where is IDEAYA Biosciences headquartered?
IDEAYA Biosciences, Inc. is headquartered in South San Francisco, California, United States.
What does IDEAYA Biosciences do?
IDEAYA Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is IDEAYA Biosciences a public company?
Yes. IDEAYA Biosciences, Inc. trades on Nasdaq under the ticker IDYA.
When was IDEAYA Biosciences founded?
The earliest incorporation on record for IDEAYA Biosciences, Inc. is in 2015, according to public company registers.
Similar companies
- CytomX Therapeutics, Inc.South San Francisco, California, United States
- Vistagen Therapeutics, Inc.South San Francisco, California, United States
- Portola Pharmaceuticals IncSouth San Francisco, California, United States
- Spruce Biosciences, Inc.South San Francisco, California, United States
- Meissa Vaccines IncSouth San Francisco, California, United States
- Oric Pharmaceuticals, Inc.South San Francisco, California, United States
- GigaGen, Inc.South San Francisco, California, United States
- Alumis Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.